IXICO PLC (IXI)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
11.50p
Buy
12.00p
0.00p (+0.00%)
Prices updated at 16 Dec 2025, 16:07 GMT
| Prices minimum 15 mins delay
Prices in GBX
IXICO PLC is engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 6m | 7m | |
| 3m | 3m | |
| -2m | -3m | |
| -36.46 | -38.51 | |
| -2m | -2m | |
| -2m | -2m | |
| Sales, General and administrative | 4m | 4m |
| Interest expenses | 25,000 | 16,000 |
| Provision for income taxes | -93,000 | -798,000 |
| Operating expenses | 5m | 6m |
| Income before taxes | -2m | -2m |
| Net income available to common shareholders | -2m | -2m |
| -0.0414 | -0.0185 | |
| Net interest income | 60,000 | 105,000 |
| Advertising and promotion | - | - |
| Net investment income, net | -52,000 | -38,000 |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -0.0414 | -0.0185 |
| Free cash flow per share | -0.0456 | -0.017 |
| Book value/share | 0.1021 | 0.1326 |
| Debt equity ratio | 0.01585 | 0.002556 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 4m | 6m |
| Current liabilities | 2m | 2m |
| Total capital | 9m | 12m |
| Total debt | 314,000 | 179,000 |
| Total equity | 9m | 12m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 11m | 14m |
| Total liabilities | - | - |
| Cash and cash equivalents | 2m | 4m |
| Common stock | 48m | 93m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 4m | 2m |
| Cash dividends paid | - | - |
| -2m | -2m | |
| Investments (gains) losses | -377,000 | -746,000 |
| 2m | 4m | |
| Net income | - | - |
| -2m | -1m | |
| -471,000 | -870,000 |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
